The Journal of Cell Communication and Signaling (JCCS) publishes fundamental and translational research into intercellular and intracellular signaling pathways.

We welcome research investigating how cells interact with their surrounding environment. Our published work also includes that showing altered cellular behavior contributing to pathological states and all aspects of remote cell signaling and communication. We are an open access title and the official journal of the International CCN Society.
 

Journal Metrics

  • 7.2CiteScore
  • 3.9Journal Impact Factor
view all metrics
Skip slideshow

Articles

ARTICLE
Open access

Cancer‐associated fibroblasts‐secreted lactate promotes RNA polymerase III subunit G‐mediated epithelial–mesenchymal transition in non‐small cell lung cancer by increasing m6A modification of zinc finger protein 384

  •  25 Jul 2025

Graphical Abstract

Cancer-associated fibroblasts-secreted lactate promotes RNA polymerase III subunit G-mediated epithelial–mesenchymal transition in non-small cell lung cancer by increasing m6A modification of zinc finger protein 384 Issue 3, 2025

In the tumor microenvironment of non-small cell lung cancer, lactate secreted by cancer-associated fibroblasts enhances the lactylation of H3K18 within the promoter region of methyltransferase-like 3 (METTL3). Furthermore, METTL3 promotes the m6A modification of zinc finger protein 384 (ZNF384) to increase its stability. The upregulation of ZNF384 transcriptionally activates polymerase III subunit G, which in turn promotes the epithelial–mesenchymal transition in cancer cells, thereby facilitating tumor progression.

ARTICLE
Open access

Y‐box binding protein 1 stabilizes EP300 mRNA and promotes forkhead box C1 H3K27Ac to aggravate chondrocyte injury in osteoarthritis

  •  23 Jul 2025

Graphical Abstract

Y-box binding protein 1 stabilizes EP300 mRNA and promotes forkhead box C1 H3K27Ac to aggravate chondrocyte injury in osteoarthritis Issue 3, 2025

In this study, YBX1 binds to EP300 mRNA and enhances its stability and expression. Subsequently, EP300 binds to the FOXC1 promoter and promotes the enrichment of H3K27Ac at the FOXC1 promoter to elevate FOXC1 expression, ultimately regulating IL-1β-induced chondrocyte damage and promoting the progression of osteoarthritis.

ARTICLE
Open access

UBD‐mediated glycolytic reprogramming promotes M2 macrophage polarization in ovarian cancer immune evasion

  •  21 Jul 2025

Graphical Abstract

UBD-mediated glycolytic reprogramming promotes M2 macrophage polarization in ovarian cancer immune evasion Issue 3, 2025

Multimodal data analysis reveals the molecular mechanism by which UBD-mediated glycolytic metabolic reprogramming regulates macrophage polarization and influences immune therapy resistance in OC.

REVIEW
Open access

A comprehensive analysis of the relationship between inflammasomes and autophagy in human tumors: Recent developments

  •  16 Jul 2025

Graphical Abstract

A comprehensive analysis of the relationship between inflammasomes and autophagy in human tumors: Recent developments Issue 3, 2025

The interaction between inflammasomes and autophagy is crucial for maintaining the balance between necessary immune responses and the avoidance of excessive inflammation. Autophagy can inhibit the activation of the NLRP3 inflammasome by degrading endogenous activators, such as damaged mitochondria that produce reactive oxygen species (ROS), as well as by eliminating components of the inflammasome and associated cytokines. Additionally, the autophagic process plays a role in the unconventional secretion of IL-1β, thereby influencing the inflammatory response. On the other hand, the activation of the NLRP3 inflammasome can also modulate the formation of autophagosomes through various mechanisms. This interplay between inflammasomes and autophagy is essential for orchestrating an appropriate host defense response while preventing detrimental inflammation.

More articles
More articles
More articles

Recent issues